Study to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN), today announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing. The study will also evaluate […]

Oncomine Dx Target Test now approved for 12 NSCLC targeted therapies globally CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific‘s Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify non-small cell lung cancer (NSCLC) patients whose tumors carry epidermal growth factor receptor (EGFR) Exon20-insertion mutations for potential […]

Maravai LifeSciences Foundation to support STEM, scientific education, community health, and COVID response SAN DIEGO — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced it is establishing a new charitable foundation to promote causes tied to Maravai’s mission. The Maravai […]

SAN DIEGO — To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of its brand new BPU™ (Biosignal Processing Unit) platform, Cardea is now unveiling a new logo, a new visual identity, a new website, and an updated focus on its core as a biocompatible semiconductor company, including establishing a new business unit […]

New NGS workflow accelerates the detection of SARS-CoV-2 variants including Omicron WALTHAM, Mass. —  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the research use only (RUO) launch of the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants. This complete next generation sequencing (NGS) solution will allow […]

BOSTON — Battery Ventures, a global, technology focused investment firm, has acquired LI-COR Biosciences, an industry-leading company that makes highly engineered instrumentation systems for environmental research, agriculture, drug discovery, protein research and therapeutics development. LI-COR, founded by Bill and Elaine Biggs, has two main business lines: environmental-monitoring instrumentation, including devices and software for scientists to […]

CONTRIBUTING TO STEM EDUCATION ENCOURAGES THE NEXT GENERATION OF SCIENTISTS IRVINE, Calif. — Zymo Research announced today that it is partnering with YARD Sciences to give high school students up-close and personal experiences with scientific laboratories. Zymo Research has donated $10,000 to YARD Sciences to help purchase vitally needed laboratory equipment to support YARD Sciences’ mission […]

MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases. The study will leverage PacBio’s HiFi long-read sequencing technology for whole genome sequencing (WGS) to look […]

– Represents First Industry Standard Control for Cancer Testing – SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of synthetic DNA using its silicon platform, today announced the launch of the Twist cfDNA Pan-cancer Reference Standards, a high-quality standardized control for use in the development and […]

Plans for Near-Term Commercialization of its Proteomics and Multi-Omics System BOSTON — NanoMosaic Inc., a Tiger Gene founded company that has established itself as the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and multi-omics applications, announced today that it has closed an oversubscribed $40,750,000 Series A round of financing led by RA Capital […]